Effect of Glucuronosyltransferase (UGT) Genetic Variation on Pharmacokinetics of Empagliflozin
NCT05036421
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Pharmacogenomic
Pharmacokinetics
Interventions
DRUG:
Empagliflozin 10 milligram
Sponsor
Ain Shams University